These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10669957)

  • 1. Endostatin: a promising drug for antiangiogenic therapy.
    Cirri L; Donnini S; Morbidelli L; Chiarugi P; Ziche M; Ledda F
    Int J Biol Markers; 1999; 14(4):263-7. PubMed ID: 10669957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
    Dhanabal M; Ramchandran R; Volk R; Stillman IE; Lombardo M; Iruela-Arispe ML; Simons M; Sukhatme VP
    Cancer Res; 1999 Jan; 59(1):189-97. PubMed ID: 9892206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
    Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
    J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.
    O'Reilly MS; Boehm T; Shing Y; Fukai N; Vasios G; Lane WS; Flynn E; Birkhead JR; Olsen BR; Folkman J
    Cell; 1997 Jan; 88(2):277-85. PubMed ID: 9008168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen XVIII/endostatin structure and functional role in angiogenesis.
    Zatterstrom UK; Felbor U; Fukai N; Olsen BR
    Cell Struct Funct; 2000 Apr; 25(2):97-101. PubMed ID: 10885579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of collagen-derived endostatin inhibitors of angiogenesis.
    Sasaki T; Hohenester E; Timpl R
    IUBMB Life; 2002 Feb; 53(2):77-84. PubMed ID: 12049199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of endostatin in experimental cancer therapy.
    Sorensen DR; Read TA
    Int J Exp Pathol; 2002 Dec; 83(6):265-74. PubMed ID: 12657135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiogenesis in tumor growth and metastasis.
    Folkman J
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo.
    Cattaneo MG; Pola S; Francescato P; Chillemi F; Vicentini LM
    Exp Cell Res; 2003 Feb; 283(2):230-6. PubMed ID: 12581742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
    Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
    Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes.
    Ergün S; Kilic N; Wurmbach JH; Ebrahimnejad A; Fernando M; Sevinc S; Kilic E; Chalajour F; Fiedler W; Lauke H; Lamszus K; Hammerer P; Weil J; Herbst H; Folkman J
    Angiogenesis; 2001; 4(3):193-206. PubMed ID: 11911017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin.
    Li M; Huang X; Zhu Z; Wong M; Watkins S; Zhao Q; Herberman R; Gorelik E
    J Immunother; 2001; 24(6):472-81. PubMed ID: 11759070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
    Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
    Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of endostatin with integrins implicated in angiogenesis.
    Rehn M; Veikkola T; Kukk-Valdre E; Nakamura H; Ilmonen M; Lombardo C; Pihlajaniemi T; Alitalo K; Vuori K
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1024-9. PubMed ID: 11158588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma.
    Ye C; Feng C; Wang S; Liu X; Lin Y; Li M
    Endocrinology; 2002 Sep; 143(9):3522-8. PubMed ID: 12193566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiostatin and endostatin: endogenous inhibitors of tumor growth.
    Sim BK; MacDonald NJ; Gubish ER
    Cancer Metastasis Rev; 2000; 19(1-2):181-90. PubMed ID: 11191058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.
    Bloch W; Huggel K; Sasaki T; Grose R; Bugnon P; Addicks K; Timpl R; Werner S
    FASEB J; 2000 Dec; 14(15):2373-6. PubMed ID: 11024009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of full-length human endostatin on in vitro angiogenesis.
    Taddei L; Chiarugi P; Brogelli L; Cirri P; Magnelli L; Raugei G; Ziche M; Granger HJ; Chiarugi V; Ramponi G
    Biochem Biophys Res Commun; 1999 Sep; 263(2):340-5. PubMed ID: 10491294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of recombinant murine endostatin in E. coli.
    You WK; So SH; Lee H; Park SY; Yoon MR; Chang SI; Kim HK; Joe YA; Hong YK; Chung SI
    Exp Mol Med; 1999 Dec; 31(4):197-202. PubMed ID: 10630374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.